“Can domain-tuned conversational AI replace the traditional BI dashboard for life sciences commercial and medical teams?”
WhizAI was founded in 2017 to bring conversational, NLP-based analytics to life sciences commercial teams, replacing dashboard-heavy BI with natural-language queries against pharma data. It scaled a domain-tuned LLM for pharma sales, medical affairs, and market analytics through 2022's Series A. It was subsequently acquired by IQVIA and now operates as 'WhizAI, an IQVIA business,' embedded into IQVIA's Analytics, Insights & Reporting (AIR) suite as the GenAI-powered conversational analytics layer.